Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) EPS (Basic) (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed EPS (Basic) for 16 consecutive years, with $0.69 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 38.0% to $0.69 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.56 through Dec 2025, up 29.95% year-over-year, with the annual reading at $2.55 for FY2025, 30.1% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.69 at Lemaitre Vascular, down from $0.77 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.77 in Q3 2025, with the low at $0.16 in Q2 2022.
  • Average EPS (Basic) over 5 years is $0.4, with a median of $0.37 recorded in 2023.
  • The sharpest move saw EPS (Basic) skyrocketed 135.29% in 2021, then crashed 60.0% in 2022.
  • Over 5 years, EPS (Basic) stood at $0.28 in 2021, then fell by 7.14% to $0.26 in 2022, then surged by 46.15% to $0.38 in 2023, then skyrocketed by 31.58% to $0.5 in 2024, then skyrocketed by 38.0% to $0.69 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $0.69, $0.77, and $0.61 for Q4 2025, Q3 2025, and Q2 2025 respectively.